Product image of Moviprep (Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, Sodium Chloride, Sodium Sulfate Anhydrous, Macr) supplied by GNH India

Moviprep

Active Ingredient:
Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, Sodium Chloride, Sodium Sulfate Anhydrous, Macr
Origin:
EU

Moviprep (Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, Sodium Chloride, Sodium Sulfate Anhydrous, Macr)

Polyethylene glycol electrolyte solution, the active ingredient in Moviprep, is an osmotic laxative presented as an oral powder for solution for oral use. It is used to cleanse the bowel in adults undergoing colonoscopy or sigmoidoscopy procedures.
GNH India supplies Moviprep as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Norgine B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moviprep, an osmotic laxative, is employed to prepare the bowel before endoscopic examinations.

  • Colonoscopy: provides thorough bowel cleansing to enable clear visualization of the colon during the procedure.
  • Sigmoidoscopy: clears the distal colon and rectum to facilitate accurate assessment.
  • Capsule endoscopy preparation: ensures adequate intestinal clearance for optimal capsule transit and imaging.

How It Works

  • Moviprep contains polyethylene glycol, a high‑molecular‑weight polymer that remains largely unabsorbed in the gastrointestinal tract. It creates an osmotic gradient that draws water into the intestinal lumen, increasing fluid volume and softening stool, which accelerates rapid bowel evacuation and clears the colon for diagnostic procedures.

Side Effects

Common Side Effects

  • Nausea: mild to moderate feeling of sickness.
  • Abdominal bloating: sensation of fullness or distension.
  • Cramping: intermittent abdominal pain.
  • Vomiting: occasional expulsion of stomach contents.
  • Thirst: increased desire for fluids.
  • Mild electrolyte changes: transient shifts in sodium or potassium levels.

Serious or Rare Side Effects

  • Severe dehydration: marked loss of body water requiring medical attention.
  • Significant electrolyte imbalance: dangerous shifts in sodium, potassium, or chloride.
  • Renal impairment: reduced kidney function, especially in susceptible patients.
  • Allergic reaction: rash, itching, or swelling.
  • Colonic perforation: rare but life‑threatening injury to the bowel wall.

Precautions & Warnings

Before using Moviprep, consider the following safety measures.

  • Renal function assessment: evaluate kidney health to avoid fluid overload.
  • Electrolyte monitoring: check serum electrolytes in patients at risk.
  • Adequate hydration: ensure sufficient fluid intake during preparation.
  • Contraindication in obstruction: do not use if intestinal blockage is present.
  • Avoid in severe dehydration: postpone until rehydration is achieved.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Moviprep may interact with other medicines; review the following.

Major Interactions (Avoid)

  • Other osmotic laxatives: combined use can cause excessive fluid loss.
  • Loop diuretics: heightened risk of electrolyte disturbances.
  • NSAIDs: increased potential for renal impairment.
  • ACE inhibitors or ARBs: may exacerbate kidney function changes.

Moderate Interactions (Monitor Closely)

  • Antacids: may alter gastrointestinal pH affecting preparation.
  • Mineral supplements (e.g., calcium, magnesium): could affect electrolyte balance.
  • Certain antibiotics (e.g., tetracyclines, quinolones): absorption may be reduced.

Frequently Asked Questions

Moviprep is a polyethylene glycol electrolyte solution used as a bowel cleansing agent to prepare the colon and rectum before procedures such as colonoscopy, sigmoidoscopy, or capsule endoscopy. It helps achieve a clear visual field by evacuating stool and residual fluid from the gastrointestinal tract.

Polyethylene glycol is a large, non‑absorbable polymer that creates an osmotic gradient in the intestine. By drawing water into the lumen, it increases fluid volume, softens stool, and promotes rapid evacuation, resulting in thorough cleansing of the bowel.

The specific dose and administration schedule of Moviprep are determined by the prescribing clinician based on the intended procedure, patient characteristics, and local guidelines. Healthcare professionals should follow the product label and clinical protocol for each individual case.

The safety of Moviprep in pregnancy or while breastfeeding has not been definitively established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To request Moviprep, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Moviprep is an osmotic laxative containing polyethylene glycol and electrolytes, offering a balanced fluid and electrolyte profile compared with sodium‑phosphate or magnesium‑based preparations. It is generally well tolerated, provides effective cleansing, and carries a lower risk of severe electrolyte shifts when used as directed.

Store Moviprep at ambient temperature, below 25 °C, in its original packaging. Protect the powder from moisture and direct sunlight to maintain stability. Do not refrigerate or freeze the product.

Moviprep is supplied as an oral powder that must be dissolved in water according to the product instructions. The solution is then consumed in divided doses as directed by the prescriber, typically with additional clear fluids to ensure adequate hydration.

Serious risks include severe dehydration, significant electrolyte disturbances (especially sodium or potassium), renal impairment, allergic reactions, and, rarely, colonic perforation. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Moviprep should be avoided in individuals with known or suspected intestinal obstruction, severe dehydration, advanced renal disease, or hypersensitivity to polyethylene glycol or any of its components. Contraindications must be assessed by a healthcare professional before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.